WO2004096248A3 - Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia - Google Patents

Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia Download PDF

Info

Publication number
WO2004096248A3
WO2004096248A3 PCT/BE2004/000059 BE2004000059W WO2004096248A3 WO 2004096248 A3 WO2004096248 A3 WO 2004096248A3 BE 2004000059 W BE2004000059 W BE 2004000059W WO 2004096248 A3 WO2004096248 A3 WO 2004096248A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
melaleuca
essential oil
quinquenervia
pure iodine
Prior art date
Application number
PCT/BE2004/000059
Other languages
English (en)
Other versions
WO2004096248A2 (fr
Inventor
Denis Mbonimpa
Original Assignee
M K M S C R L
Denis Mbonimpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M K M S C R L, Denis Mbonimpa filed Critical M K M S C R L
Priority to CA002524092A priority Critical patent/CA2524092A1/fr
Priority to EP04729797A priority patent/EP1628672A2/fr
Publication of WO2004096248A2 publication Critical patent/WO2004096248A2/fr
Publication of WO2004096248A3 publication Critical patent/WO2004096248A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition ainsi que la production et l’utilisation de cette nouvelle composition. La composition est obtenue par dissolution instantanée de l’iode pur à l’état solide dans l’huile essentielle de Mélaleuca Alternifolia (tea tree) et/ou Quinquinervia (Niaouli). Cette composition est stable et peut être utilisée pour le traitement de l’herpès labial et/ou génital.
PCT/BE2004/000059 2003-04-28 2004-04-28 Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia WO2004096248A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002524092A CA2524092A1 (fr) 2003-04-28 2004-04-28 Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia
EP04729797A EP1628672A2 (fr) 2003-04-28 2004-04-28 Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2003/0265 2003-04-28
BE2003/0265A BE1015498A5 (fr) 2003-04-28 2003-04-28 Composition et utilisation de l'iode pur dissout dans l'huile essentielle de melaleuca alternifolia et/ou de melaleuca quinquinervia.

Publications (2)

Publication Number Publication Date
WO2004096248A2 WO2004096248A2 (fr) 2004-11-11
WO2004096248A3 true WO2004096248A3 (fr) 2005-01-13

Family

ID=33315071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE2004/000059 WO2004096248A2 (fr) 2003-04-28 2004-04-28 Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia

Country Status (4)

Country Link
EP (1) EP1628672A2 (fr)
BE (1) BE1015498A5 (fr)
CA (1) CA2524092A1 (fr)
WO (1) WO2004096248A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078845B2 (en) 2005-01-20 2015-07-14 Kayban Pty Ltd Anti-microbial agent
IL192335A0 (en) * 2008-06-19 2011-08-01 Avivi Easy Life Ltd Antiviral compounds
ITRE20090011A1 (it) * 2009-02-11 2010-08-12 Gianni Magnanini Composizione terapeutica per il trattamento dell'herpes labialis

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB589097A (en) * 1945-02-15 1947-06-11 Parisepsin Ltd Improvements in or relating to the manufacture of antiseptic preparations
DD210384A3 (de) * 1982-09-24 1984-06-06 Pharmazeutisches Werk Halle Bo Verfahren zur herstellung eines medizinischen schwefelbades mit komplexer wirkung
WO1994000126A1 (fr) * 1992-06-30 1994-01-06 Montefarmaco S.P.A. Utilisation d'acides biliaires comme agents antiviraux
US5972362A (en) * 1997-12-23 1999-10-26 Wenker; Naamah T. Therapeutic skin preparation
US6019941A (en) * 1996-01-30 2000-02-01 Porcello; Joseph A. Method for disinfecting dermal surfaces and inanimate surfaces, and particularly air ducts
RU2150935C1 (ru) * 1999-06-22 2000-06-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
WO2001087247A2 (fr) * 2000-05-18 2001-11-22 Elena Lurya Composition a base d'herbes medicinales utiles dans le traitement de la cavite buccale et procede d'administration de cette composition
RU2178290C1 (ru) * 2000-11-22 2002-01-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
EP1236466A1 (fr) * 2001-02-28 2002-09-04 Efrat Biopolymers Ltd. Compositions absorbables solides pour le traitement topique des troubles de la muqueuse orale

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB589097A (en) * 1945-02-15 1947-06-11 Parisepsin Ltd Improvements in or relating to the manufacture of antiseptic preparations
DD210384A3 (de) * 1982-09-24 1984-06-06 Pharmazeutisches Werk Halle Bo Verfahren zur herstellung eines medizinischen schwefelbades mit komplexer wirkung
WO1994000126A1 (fr) * 1992-06-30 1994-01-06 Montefarmaco S.P.A. Utilisation d'acides biliaires comme agents antiviraux
US6019941A (en) * 1996-01-30 2000-02-01 Porcello; Joseph A. Method for disinfecting dermal surfaces and inanimate surfaces, and particularly air ducts
US5972362A (en) * 1997-12-23 1999-10-26 Wenker; Naamah T. Therapeutic skin preparation
RU2150935C1 (ru) * 1999-06-22 2000-06-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
WO2001087247A2 (fr) * 2000-05-18 2001-11-22 Elena Lurya Composition a base d'herbes medicinales utiles dans le traitement de la cavite buccale et procede d'administration de cette composition
RU2178290C1 (ru) * 2000-11-22 2002-01-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
EP1236466A1 (fr) * 2001-02-28 2002-09-04 Efrat Biopolymers Ltd. Compositions absorbables solides pour le traitement topique des troubles de la muqueuse orale

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch 2000 Derwent World Patents Index; Class D21, AN 2000-663199, XP002260200, A.GRECHKO E.A.: "Protective and prophylactic cream" *
DATABASE WPI Section Ch Week 200224, 2002 Derwent World Patents Index; Class B05, AN 2002-186919, XP002260201, YU. N. PERLAMUTROV: "Protective-prophylactic cream" *

Also Published As

Publication number Publication date
BE1015498A5 (fr) 2005-05-03
EP1628672A2 (fr) 2006-03-01
CA2524092A1 (fr) 2004-11-11
WO2004096248A2 (fr) 2004-11-11

Similar Documents

Publication Publication Date Title
WO2009019571A3 (fr) Procede de solubilisation d'huiles essentielles dans l'eau
WO2006110406A3 (fr) Compositions comprenant des composants probiotiques et des composants edulcorants
WO2009010305A3 (fr) Formulations d'ingrédients de santé lipophiles pouvant se présenter sous forme de comprimés
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
TW200630478A (en) Processes for preparation of oil compositions
WO2007104575A3 (fr) Compositions de pastilles stables à libération rapide de nicotine
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
WO2006127772A3 (fr) Compositions de tabac
WO2006133410A3 (fr) Compositions ceramiques biocides, procedes et articles manufactures
WO2006010591A3 (fr) Derives de quinazoline
WO2006057857A3 (fr) Compositions et procedes destines a blanchir, a mineraliser et/ou a fluorer des tissus calcifies
WO2008035020A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
WO2009044648A1 (fr) Agent anti-allergène
CA2668320A1 (fr) Utilisation de 3-alpha-androstanediol, eventuellement en combinaison avec un agoniste 5-ht1a, dans le traitement du dysfonctionnement sexuel
WO2009004629A3 (fr) Procédé pour réduire les symptômes de consommation d'alcool
WO2008025819A3 (fr) Formulations de l'acide acétylsalicylique ou de ses dérivés dans des capsules molles, présentant une stabilité élevée
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
WO2007038627A3 (fr) Compositions antimicrobiennes stabilisees et methodes de preparation associees
WO2008090740A1 (fr) Gâteaux
WO2007075255A3 (fr) Composition de gomme mastic utilisable en tant que complement alimentaire pour les humains et les animaux
WO2005051083A3 (fr) Composes molluscicides et anti-anatifes
WO2005063195A3 (fr) Compositions comprenant des vitamines et/ou des derives de celles-ci stabilises au moyen d'extrait d'olea europea et/ou de polymeres ionene
WO2004096248A3 (fr) Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia
WO2007014379A3 (fr) Extrait lipidique provenant de lepidium meynii et effet de celui-ci sur la libido
WO2004073686A3 (fr) Solutions de medicaments dans du menthol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2524092

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004729797

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004729797

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004729797

Country of ref document: EP